Literature DB >> 16516133

History of the treatment of childhood ALL: a paradigm for cancer cure.

Joseph V Simone1.   

Abstract

The history of the treatment of childhood leukemia from 1950 to the present is reviewed here. Particular emphasis is placed on the 'Total Therapy' studies conducted at St Jude Children's Research Hospital in Memphis, Tennessee. Under the guidance of Donald Pinkel, MD, the first medical director of St Jude, variations in chemotherapy and craniospinal irradiation were tried, and by Study XV, begun in 2000, a 4-year event-free survival of 92+/-7% had been achieved. Strengths and weaknesses in the current treatment of childhood leukemia are discussed as well as possibilities for the future.

Entities:  

Mesh:

Year:  2006        PMID: 16516133     DOI: 10.1016/j.beha.2005.11.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  16 in total

Review 1.  Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948.

Authors:  Peter D Spain; Nina Kadan-Lottick
Journal:  J R Soc Med       Date:  2012-04       Impact factor: 5.344

2.  Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.

Authors:  Yin Ting Cheung; Kevin R Krull
Journal:  Neurosci Biobehav Rev       Date:  2015-04-07       Impact factor: 8.989

Review 3.  Central nervous system disease in hematologic malignancies: historical perspective and practical applications.

Authors:  Ching-Hon Pui; Eckhard Thiel
Journal:  Semin Oncol       Date:  2009-08       Impact factor: 4.929

4.  Pediatric Leukemia, Psychosocial Dimensions of Cures, and Implications for HIV.

Authors:  Catherine Gliwa; Mary E Grewe; Stuart Rennie; Joseph Tucker; Raul Necochea
Journal:  Pediatrics       Date:  2016-03-03       Impact factor: 7.124

5.  Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.

Authors:  Eric W Tai; Kevin C Ward; Audrey Bonaventure; David A Siegel; Michel P Coleman
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

6.  A grounded theory of the process of adherence to oral chemotherapy in Hispanic and caucasian children and adolescents with acute lymphoblastic leukemia.

Authors:  Wendy Landier; Cynthia B Hughes; Evelyn R Calvillo; Nancy L R Anderson; Deborah Briseño-Toomey; Leticia Dominguez; Alex M Martinez; Cara Hanby; Smita Bhatia
Journal:  J Pediatr Oncol Nurs       Date:  2011-06-08       Impact factor: 1.636

7.  New considerations in the design of clinical trials for the treatment of acute leukemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Clin Investig (Lond)       Date:  2011-04-01

8.  Neurocognitive Late Effects of Chemotherapy in Survivors of Acute Lymphoblastic Leukemia: Focus on Methotrexate.

Authors:  Ellen van der Plas; Brian J Nieman; Darci T Butcher; Johann K Hitzler; Rosanna Weksberg; Shinya Ito; Russell Schachar
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2015-03-04

Review 9.  Central nervous system niche involvement in the leukemia.

Authors:  N Heidari; N Saki; L De Filippis; M Shahjahani; A Teimouri; A Ahmadzadeh
Journal:  Clin Transl Oncol       Date:  2015-08-05       Impact factor: 3.405

Review 10.  Research as a Standard of Care in the PICU.

Authors:  Jerry J Zimmerman; Kanwaljeet J S Anand; Kathleen L Meert; Douglas F Willson; Christopher J L Newth; Rick Harrison; Joseph A Carcillo; John Berger; Tammara L Jenkins; Carol Nicholson; J Michael Dean
Journal:  Pediatr Crit Care Med       Date:  2016-01       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.